Bromide

Bromide

SCHEMBL1301958

C=CC(=O)OC(CC)[N+](C)(C)C.[Br-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.38
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.35
ALDH1A1 P00352 4/20 0.32
TP53 P04637 2/20 0.32
HIF1A Q16665 2/20 0.32
CYP3A4 P08684 1/20 0.32
HSD17B10 Q99714 1/20 0.32
THRB P10828 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764767 0.98 TSHR (0.39) TSHRHPGDALOX15ALDH1A1TP53
Hydrochloric Acid SCHEMBL129465 0.96 ALOX15 (0.39) TSHRHPGDALOX15ALDH1A1TP53
Fluoride Ion SCHEMBL1302572 0.96 TSHR (0.38) TSHRHPGDALOX15ALDH1A1TP53
Iodide SCHEMBL1301568 0.96 TSHR (0.38) TSHRHPGDALOX15ALDH1A1TP53
SCHEMBL28592184 0.91 TSHR (0.35) TSHRHPGDALOX15
SCHEMBL27632852 0.85 TSHR (0.32) TSHRHPGD
Bromide SCHEMBL1301314 0.85 TSHR (0.39) TSHRHPGDALOX15ALDH1A1TP53
SCHEMBL28630599 0.83 TSHR (0.40) TSHRHPGDALOX15ALDH1A1TP53
SCHEMBL3760073 0.83 TSHR (0.37) TSHRHPGDALDH1A1TP53HIF1A
Bromide SCHEMBL130776 0.83 TSHR (0.37) TSHRHPGDALDH1A1TP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570860-B2 Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
CN-117586645-A Coloring composition containing dioxazine pigment and color filter 大塚化学株式会社 2024-02-23 CN disclosed
CN-113166050-B Method for producing organotellurium compound and method for producing vinyl polymer 大塚化学株式会社 2023-04-18 CN disclosed
US-20220267615-A1 TWO-COMPONENT TREATMENT AGENT, TREATMENT METHOD FOR MAKING METAL SURFACE ANTIBACTERIAL AND ANTIBACTERIAL TREATMENT AGENT TOKYO OHKA KOGYO CO., LTD. (JP) 2022-08-25 US disclosed
CN-111971116-B Dispersant composition, coloring composition and color filter 大塚化学株式会社 2022-06-28 CN disclosed
CN-113166050-A Method for producing organic tellurium compound and method for producing vinyl polymer 大塚化学株式会社 2021-07-23 CN disclosed
CN-108431064-B Block copolymer, dispersant and pigment dispersion composition 大塚化学株式会社 2021-03-12 CN disclosed
CN-111971116-A Dispersant composition, coloring composition and color filter 大塚化学株式会社 2020-11-20 CN disclosed
CN-104375396-A Method for preparing color carbon powder by adopting suspension polymerization method HUBEI DINGLONG CHEMICAL CO LTD 2015-02-25 CN disclosed
EP-2387866-A1 ELECTROMAGNETIC WAVE SHIELDING GEL-LIKE COMPOSITION 3M Innovative Properties Company (US) 2011-11-23 EP disclosed
US-20110268950-A1 Electromagnetic Wave Shielding Gel-Like Composition 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-11-03 US disclosed
US-8038066-B2 Laser scanner with deformable lens HAND HELD PRODUCTS, INC. (US) 2011-10-18 US disclosed
WO-2010083075-A1 ELECTROMAGNETIC WAVE SHIELDING GEL-LIKE COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570860-B2 Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent SARS1, ACE2, EIF2AK2 TSHR 3546/4885HPGD 4797/4885ALOX15 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.